Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Cut to $16.00

Bioceres Crop Solutions (NASDAQ:BIOX) had its price objective reduced by analysts at Oppenheimer from $17.00 to $16.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s target price suggests a potential upside of 86.05% from the stock’s current price.

A number of other analysts have also recently commented on BIOX. Roth Capital raised Bioceres Crop Solutions to a “strong-buy” rating in a research note on Tuesday, July 2nd. Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Roth Mkm assumed coverage on Bioceres Crop Solutions in a report on Tuesday, July 2nd. They set a “buy” rating and a $15.00 price target for the company. Canaccord Genuity Group restated a “buy” rating and set a $17.00 price objective on shares of Bioceres Crop Solutions in a report on Friday, July 19th. Finally, Lake Street Capital lowered their price target on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday. Four analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $13.63.

Bioceres Crop Solutions Stock Up 0.6 %

Bioceres Crop Solutions stock opened at $8.60 on Wednesday. The firm has a market cap of $540.05 million, a PE ratio of 860.00 and a beta of 0.49. Bioceres Crop Solutions has a twelve month low of $8.16 and a twelve month high of $14.05. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.83 and a current ratio of 1.22. The firm’s 50 day moving average price is $10.49 and its two-hundred day moving average price is $11.45.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings data on Monday, September 9th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.23). Bioceres Crop Solutions had a return on equity of 0.28% and a net margin of 0.21%. The business had revenue of $124.30 million for the quarter, compared to analyst estimates of $126.75 million. During the same period in the prior year, the firm posted ($0.06) EPS. On average, research analysts predict that Bioceres Crop Solutions will post 0.3 EPS for the current fiscal year.

Institutional Trading of Bioceres Crop Solutions

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Fourth Sail Capital LP raised its position in shares of Bioceres Crop Solutions by 136.1% during the 1st quarter. Fourth Sail Capital LP now owns 1,627,630 shares of the company’s stock valued at $20,606,000 after purchasing an additional 938,282 shares during the period. Sumitomo Mitsui Trust Holdings Inc. purchased a new stake in Bioceres Crop Solutions during the second quarter valued at approximately $472,000. Oppenheimer & Co. Inc. purchased a new stake in Bioceres Crop Solutions during the 1st quarter valued at $139,000. Wellington Management Group LLP lifted its holdings in shares of Bioceres Crop Solutions by 3.1% in the 4th quarter. Wellington Management Group LLP now owns 236,906 shares of the company’s stock worth $3,253,000 after acquiring an additional 7,096 shares during the last quarter. Finally, Ping Capital Management Inc. purchased a new position in shares of Bioceres Crop Solutions during the second quarter valued at approximately $448,000. 17.68% of the stock is currently owned by institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.